Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer

Background: Single-agent capecitabine (C) is a moderately effective chemotherapeutic compound in the treatment of patients with HER2-negative metastatic breast cancer (mBC). The capecitabine-vinorelbine (CV) combination is also used due to a good tolerability profile, but no studies have demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernieri, Claudio, Prisciandaro, Michele, Nichetti, Federico, Lobefaro, Riccardo, Peverelli, Giorgia, Ligorio, Francesca, Zattarin, Emma, Cona, Maria Silvia, Sepe, Pierangela, Corti, Francesca, Manglaviti, Sara, Brambilla, Marta, Re, Barbara, Belfiore, Antonino, Pruneri, Giancarlo, Celio, Luigi, Mariani, Gabriella, Bianchi, Giulia Valeria, Rivoltini, Licia, Capri, Giuseppe, de Braud, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139362/
https://www.ncbi.nlm.nih.gov/pubmed/32155941
http://dx.doi.org/10.3390/cancers12030617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139362/
https://www.ncbi.nlm.nih.gov/pubmed/32155941
http://dx.doi.org/10.3390/cancers12030617

Ejemplares similares